Realbotix (XBOT.F) Investor presentation summary

Strategic developments and transactions

• Entered a reverse-takeover agreement with Onconetix, leading to a planned NASDAQ listing and Realbotix Corp. owning 75–90% of the new entity, valuing Realbotix, LLC at $125 million, with closing expected before Q3 2026 end.

• Transaction aims to provide capital for growth without dilution and broaden investor access via NASDAQ.

Technology and product innovation

• Specializes in lifelike humanoid robots with embedded AI for vision, reasoning, and social engagement, manufactured in the USA.

• Holds patents for modular face technology, robotic vision, and synthetic skin; proprietary AI is customizable, multilingual, and portable.

• Robots feature up to 43 degrees of freedom, realistic skin, modularity, and support for major AI platforms.

• AI vision enables mood interpretation, object recognition, and autonomous response without teleoperation.

Commercial achievements and deployments

• Achieved several industry firsts, including live TV interviews, customer service robots in malls, and robot greeters at major events.

• Case studies show robots deployed in retail, conferences, and tech demonstrations, proving commercial viability and scalability.

• Recurring revenue streams from AI agent subscriptions and hardware/software updates.